Hematology/Oncology News

The FDA approved amivantamab-vmjw in combination with standard chemotherapy for the treatment of certain adults with non-small cell lung cancer, according to the agent’s manufacturer.

The introduction of immunotherapy to treatment paradigms has improved survival for patients with metastatic non-small cell lung cancer, according to study results.

Approximately half of the 18 million cancer survivors in the United States are of working age.

PROVIDENCE, Rhode Island — The influence digital opinion leaders have on health care stakeholders and patients will continue to grow as new opportunities for education and collaboration arise, according to a presenter at the COSMO Meeting.

The FDA has granted fast track designation to topically applied ATR-04 for the treatment of moderate to severe epidermal growth factor receptor inhibitor-associated dermal toxicity, Azitra announced in a press release.

PROVIDENCE, Rhode Island — Misinformation about cancer is prevalent on social media, spanning across platforms and malignancy types, according to a presenter at the COSMO Meeting.

Cemiplimab provided clinically meaningful responses for patients with metastatic and locally advanced cutaneous squamous cell carcinoma, according to a study.

CHICAGO — The way that clinicians are taught to deal with feelings in medicine is complex, according to Jessi Gold, MD, MS.

Greater utilization of genetic testing among men could have considerable benefits with regard to detection, risk management and personalized treatment of cancers, according to authors of a review published in JAMA Oncology.

Manuka honey may represent an alternative natural approach to reducing tumor growth in breast cancer, according to research conducted at UCLA Health Jonsson Comprehensive Cancer Center.